Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Heron Therapeutics Inc (HRTX) vs iShares MSCI China ETF (MCHI) Price & Performance

Heron Therapeutics IncTrade
iShares MSCI China ETFTrade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs iShares MSCI China ETF — how do they compare? Heron Therapeutics Inc trades at $0.31 (market cap $61.47M), while iShares MSCI China ETF trades at $55.17. The key difference: iShares MSCI China ETF is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.

HRTXMCHI
Market Cap
$61.47M
Sector
HealthBroad Market / Factor
52-Week High
$1.49$66.99
52-Week Low
$0.32$50.48
Enterprise Value
$168.21M

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX

About iShares MSCI China ETF

MCHI is an ETF that seeks to track the investment results of the MSCI China Index. It provides broad exposure to the Chinese equity market, primarily focusing on large and mid-cap companies listed in Hong Kong and Shanghai. MCHI serves as a core holding for investors looking to gain diversified exposure to the performance and growth potential of the companies within the People's Republic of China.

Read more on MCHI